The FlowSyn™ from Uniqsis is a compact integrated continuous flow reactor system designed for easy, safe and efficient operation.
Application Note 29 describes an efficient continuous flow synthesis protocol to create a new library of pyrazoles developed by chemists at GalChimia (Coruna, Spain) on a FlowSyn™ continuous flow reactor system.
The aim of the described work was to develop a new continuous flow protocol to replace the traditional 2-step synthesis and to examine the scope of the new methodology. The authors of the application note demonstrate how using the FlowSyn system a range of conditions could be quickly evaluated under flow-through conditions thereby facilitating rapid reaction optimisation. In addition, using the FlowSyn system useful quantities of a wide range of pyrazoles could be prepared in less than 1 hour each.
The CEO of GalChimia commented “Taking in account all the data we gathered in the different experiments, we can conclude that the tandem synthesis of pyrazoles using the Uniqsis FlowSyn™ system offers a general, high-yielding method to prepare these compounds, which can be used with many different substrates”.
The FlowSyn™ continuous flow reactor range includes models for performing single or multiple homogeneous or heterogeneous reactions, either manually or automatically. The range of chemistries that can be explored with Uniqsis’ integrated and modular flow chemistry systems grows ever wider and is exemplified by the growing number of applications published both in the academic press and in Uniqsis’ own application notes. Typical examples of flow chemistry applications include hydrogenation, nitration, bromination, metalation, molecular rearrangements and synthesis of compounds such as dihyropyridine, indole, pyrazole, quinolinone and benzimidazole.
To download a copy of the GalChimia application note 29 please visit http://www.uniqsis.com/fcApplications.aspx. For further information on the FlowSyn™ system please visit https://www.uniqsis.com/paFlowSystem.aspx or contact Uniqsis on +44-845-864-7747 / [email protected].
